$406 Million is the total value of Nekton Capital Ltd.'s 13 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 92.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TMX | Buy | TERMINIX GLOBAL | $60,888,000 | +61.8% | 1,334,393 | +60.4% | 15.00% | -34.2% |
| QGEN | Buy | QIAGEN NV | $54,592,000 | +250.5% | 1,114,127 | +298.6% | 13.45% | +42.6% |
| AZPN | Buy | ASPEN TECHNOLOGY | $47,230,000 | +196.7% | 285,603 | +173.0% | 11.64% | +20.7% |
| ICE | Buy | INTERCONTINENTAL | $39,501,000 | +640.6% | 298,976 | +666.6% | 9.73% | +201.3% |
| MRVI | New | MARAVAI LIFESC-A | $39,189,000 | – | 1,111,102 | +100.0% | 9.66% | – |
| MNST | Buy | MONSTER BEVERAGE | $35,257,000 | +220.3% | 441,264 | +285.1% | 8.69% | +30.3% |
| CNHI | Buy | CNH INDUSTRIAL N | $33,017,000 | +45.5% | 2,081,790 | +78.3% | 8.14% | -40.8% |
| ZBH | New | ZIMMER BIOMET HO | $30,339,000 | – | 237,211 | +100.0% | 7.48% | – |
| PLAN | New | ANAPLAN INC | $23,506,000 | – | 361,355 | +100.0% | 5.79% | – |
| EHC | New | ENCOMPASS HEALTH | $18,501,000 | – | 260,172 | +100.0% | 4.56% | – |
| SWCH | New | SWITCH INC- Acl a | $11,829,000 | – | 383,812 | +100.0% | 2.92% | – |
| ENV | New | ENVESTNET INC | $8,908,000 | – | 119,661 | +100.0% | 2.20% | – |
| NUVA | Sell | NUVASIVE INC | $3,058,000 | -73.3% | 53,933 | -75.3% | 0.75% | -89.1% |
| BNTX | Exit | BIONTECH SE-ADRsponsored ads | $0 | – | -4,772 | -100.0% | -0.70% | – |
| ZEN | Exit | ZENDESK INC | $0 | – | -12,625 | -100.0% | -0.80% | – |
| MNTV | Exit | MOMENTIVE GLOBAL | $0 | – | -182,965 | -100.0% | -2.34% | – |
| BKNG | Exit | BOOKING HOLDINGS | $0 | – | -2,268 | -100.0% | -3.30% | – |
| TXT | Exit | TEXTRON INC | $0 | – | -138,460 | -100.0% | -6.48% | – |
| BKI | Exit | BLACK KNIGHT | $0 | – | -132,845 | -100.0% | -6.67% | – |
| FLOW | Exit | SPX FLOW INC | $0 | – | -138,440 | -100.0% | -7.25% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QIAGEN NV | 8 | Q3 2023 | 20.1% |
| JACOBS SOLUTIONS | 5 | Q3 2023 | 6.8% |
| ZIMMER BIOMET HO | 4 | Q4 2022 | 9.7% |
| CNH INDUSTRIAL N | 4 | Q3 2022 | 13.7% |
| HORIZON THERAPEU | 4 | Q2 2023 | 9.4% |
| TERMINIX GLOBAL | 3 | Q2 2022 | 22.8% |
| UNION PAC CORP | 3 | Q3 2023 | 10.5% |
| EMERSON ELEC CO | 3 | Q3 2023 | 8.7% |
| ALCON INC | 3 | Q2 2023 | 11.4% |
| PTC INC | 3 | Q3 2023 | 8.1% |
View Nekton Capital Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-10 |
View Nekton Capital Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.